I
InsightRX
Precision medicine made simple.
About InsightRX
InsightRX is a cloud-based clinical decision support platform designed to help healthcare providers individualize patient treatment at the point of care. The company operates in the healthcare technology market, focusing on precision dosing for medications with narrow therapeutic windows, such as vancomycin. InsightRX serves clinicians and healthcare institutions, providing tools to improve dosing accuracy and patient outcomes through real-time clinical analytics and continual model updates based on real-world data. The business model includes standalone online services and integrations with Electronic Health Records (EHR) systems, generating revenue through subscription fees and partnerships. InsightRX's platform is recognized for its ability to enhance patient safety and streamline the treatment process, making it a valuable asset for healthcare providers aiming to reach clinical targets more efficiently.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- San Francisco, United States
- Employees
- 32
- Open positions
- 1
- Dealroom signal
- 79.4/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Predictive Analytics, Biotechnology, Patient Care, Medical Imaging, Core AI, Precision Medicine, Spinout
- Technology
- Artificial Intelligence, Hardware, Deep Tech, Machine Learning
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Feb 2024 | $0 | — | CIBC Innovation Banking | ↗ |
| SERIES A✓Equity / VC | Sep 2019 | $10M | $40M | Rock Health · Leawood Venture Capital · Premier · GreatPoint Ventures | — |
Growth signals
Latest recorded traffic for InsightRX is 5.3K monthly website visits, up 43.2% over the last three months. InsightRX's team grew 6.7% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
Deep LensSaas-based precision medicine software suite |
Columbus, United States | Acquired | 6 | $17M | $56M |
IcometrixAI-powered software for quantitative brain scan analysis |
Leuven, Belgium | Acquired | |||
OptellumDeveloping an artificial intelligence software platform to support clinicians in lung cancer nodule management |
Oxford, United Kingdom | Operational | |||
Sophia GeneticsHelps clinicians and physicians predict genetic diseases better |
Saint-Sulpice, Switzerland | Operational | |||
PixylNeuroimaging AI for Improved Patient Care |
La Tronche, France | Acquired | |||
AlgoDxDeveloping a new category of diagnostics in the form SaMD |
Stockholms kommun, Sweden | Operational | |||
KribaNon-invasive screening and monitoring of serous fluids infections of the body |
Madrid, Spain | Operational | |||
ProsciaDeveloper of pathology cloud technology for use in medicine |
Philadelphia, United States | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Launchpad Digital Health
Plug and Play
Series A7 investors entered at this stage
GreatPoint Ventures
FundersClub
HealthX Ventures
Rock Health
Leawood Venture Capital
Premier
CIBC Innovation Banking
Other known investors8 additional known investors
University of California, San Francisco
Comet Labs
MIKE McCORMICK
Mission and Market
OSF
Prado SV
Rock Health Capital
WorldQuant Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about InsightRX on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See InsightRX’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







